TOKYO -- Fujifilm Holdings will acquire a Danish biopharmaceutical production unit of U.S. company Biogen for an estimated $890 million, the Japanese company's latest effort to strengthen health care operations and ease its reliance on office equipment.
Under the deal announced Tuesday, Tokyo-based Fujifilm will gain production facilities in Denmark, as well as 800 or so workers there and supply contracts with large drugmakers. Biopharmaceuticals are highly effective in treating rare diseases and carry relatively few side effects.
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
